Blood coagulation changes under L-asparaginase therapy.
D000328:Adult; D000368:Aged; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects*; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D001779:Blood Coagulation Factors / Q000378:metabolism; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000032:analysis; D001798:Blood Proteins / Q000378:metabolism; D003018:Clot Retraction; D005260:Female; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D007456:Iodine Isotopes; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008206:Lymphatic Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D010958:Plasminogen / Q000378:metabolism; D014594:Uterine Neoplasms / Q000188:drug therapy
D001779:Blood Coagulation Factors; D001798:Blood Proteins; D007456:Iodine Isotopes; D010958:Plasminogen; D005341:Fibrinolysin; D001215:Asparaginase